JP2023522198A5 - - Google Patents
Info
- Publication number
- JP2023522198A5 JP2023522198A5 JP2022562788A JP2022562788A JP2023522198A5 JP 2023522198 A5 JP2023522198 A5 JP 2023522198A5 JP 2022562788 A JP2022562788 A JP 2022562788A JP 2022562788 A JP2022562788 A JP 2022562788A JP 2023522198 A5 JP2023522198 A5 JP 2023522198A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20170174.5 | 2020-04-17 | ||
| EP20170174 | 2020-04-17 | ||
| PCT/US2021/028029 WO2021212123A1 (en) | 2020-04-17 | 2021-04-19 | Fusion proteins of ctl antigens for treating melanoma |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023522198A JP2023522198A (ja) | 2023-05-29 |
| JP2023522198A5 true JP2023522198A5 (https=) | 2024-05-20 |
| JPWO2021212123A5 JPWO2021212123A5 (https=) | 2024-05-20 |
Family
ID=70295067
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022562788A Pending JP2023522198A (ja) | 2020-04-17 | 2021-04-19 | 黒色腫を治療するためのｃｔｌ抗原の融合タンパク質 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230167163A1 (https=) |
| EP (1) | EP4136097A1 (https=) |
| JP (1) | JP2023522198A (https=) |
| CN (1) | CN116057067A (https=) |
| CA (1) | CA3179694A1 (https=) |
| WO (1) | WO2021212123A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021005338A2 (en) * | 2019-07-05 | 2021-01-14 | The Francis Crick Institute Limited | Novel cancer antigens and methods |
| JP2023522193A (ja) * | 2020-04-17 | 2023-05-29 | ザ フランシス クリック インスティチュート リミティッド | 抗原プール |
| WO2025202937A1 (en) | 2024-03-26 | 2025-10-02 | BioNTech SE | Cancer vaccines |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1053325E (pt) * | 1998-02-05 | 2006-05-31 | Glaxosmithkline Biolog Sa | Derivados de antigenios associados a tumores da familia mage e, sequencias de acidos nucleicos que os codificam, utilizados para a preparacao de proteinas de fusao e de composicoes para vacinacao. |
| CN100419079C (zh) * | 1998-07-14 | 2008-09-17 | 科里克萨有限公司 | 用于治疗和诊断前列腺癌的组合物和方法 |
| US6770456B1 (en) | 1998-07-29 | 2004-08-03 | Ludwig Institute For Cancer Research | Endogenous retrovirus tumor associated nucleic acids and antigens |
| US20040142325A1 (en) * | 2001-09-14 | 2004-07-22 | Liat Mintz | Methods and systems for annotating biomolecular sequences |
| EP1586330A1 (en) * | 2004-04-16 | 2005-10-19 | Georg-August-Universität Göttingen | Vaccination against malignant melanoma |
| DK1871391T3 (da) | 2005-03-30 | 2012-04-16 | Viroxis | Endogen retrovirus og proteiner, der kodes af env som target for cancerbehandling |
| AT502292B1 (de) | 2005-05-11 | 2010-04-15 | Avir Green Hills Biotechnology | Melanomdiagnose |
| US8921050B2 (en) | 2006-03-17 | 2014-12-30 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods of diagnosing renal cell carcinoma |
| US20080019979A1 (en) | 2006-05-22 | 2008-01-24 | Feng Wang-Johanning | HERV-K Antigens, Antibodies, and Methods |
| CN101638440B (zh) * | 2008-07-29 | 2011-10-26 | 中国人民解放军军事医学科学院基础医学研究所 | 一种可诱发机体抗肿瘤免疫的异种抗原-Fc融合蛋白及其应用 |
| BR112021006941A2 (pt) * | 2018-10-19 | 2021-08-31 | The Francis Crick Institute Limited | Antígenos de câncer inovadores e métodos |
| AU2020302285A1 (en) * | 2019-06-28 | 2021-12-02 | Enara Bio Limited | Novel cancer antigens and methods |
| WO2021005338A2 (en) * | 2019-07-05 | 2021-01-14 | The Francis Crick Institute Limited | Novel cancer antigens and methods |
-
2021
- 2021-04-19 CN CN202180043464.9A patent/CN116057067A/zh active Pending
- 2021-04-19 CA CA3179694A patent/CA3179694A1/en active Pending
- 2021-04-19 JP JP2022562788A patent/JP2023522198A/ja active Pending
- 2021-04-19 WO PCT/US2021/028029 patent/WO2021212123A1/en not_active Ceased
- 2021-04-19 EP EP21723936.7A patent/EP4136097A1/en active Pending
-
2022
- 2022-10-14 US US18/046,675 patent/US20230167163A1/en active Pending